Global Leaders in Mobile ECG Connectivity
- 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring platforms, research groups and commercial call centers
- Sold into > 20 countries, with the largest customer base located in the US
- Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and storing of ECGs for management of patient and consumer health
- ECG solutions for both consumer (OTC) and medical (Rx) markets
- Owns all IP and source code
- Market expert contributor for reports in mâ€health, mobile cardiac monitoring and new advances in consumer health and wellness monitoring
Company Accolades
Recent Highlights
-
Company collaborates with ZANA Technologies GmbH to integrate mobile ECG management and Smartphone App technologies
- ECG technologies to be tested within ZANA’s remote patient monitoring platform in 2020
- CardioComm’s GEMS™ ECG reviewing and HeartCheck™ ECG monitoring technologies are being evaluated to support ZANA’s novel, voice-directed, remote patient monitoring and patient management platform.
Industry News
- INDUSTRY BULLETIN: mHealth is Expected to Double Its Market Size in Upcoming Years
- INDUSTRY BULLETIN: FDA Unveils mHealth App to Crowdsource Elusive Disease Treatments
- INDUSTRY BULLETIN: mHealth Device Market Rise +35.03% of CAGR By Upcoming Developments + Future Investment
- INDUSTRY BULLETIN: How mHealth apps are providing solutions to the healthcare market’s problems
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.